SCHEMBL4652020

SCHEMBL4652020

N=C(N)c1cccc(CC(NC(=O)NC(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.54
F2 P00734 9/20 0.52
F10 P00742 5/20 0.52
PRSS1 P07477 4/20 0.52
TMPRSS6 Q8IU80 6/20 0.50
KLKB1 P03952 3/20 0.45
PLG P00747 1/20 0.45
PROC P04070 1/20 0.45
NPFFR1 Q9GZQ6 2/20 0.44
NPFFR2 Q9Y5X5 2/20 0.44
NPY1R P25929 2/20 0.44
NPY5R Q15761 1/20 0.44
ANPEP P15144 1/20 0.43
CTSL P07711 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8147709 0.89 NPY1R (0.45) F7KLKB1NPFFR1NPFFR2NPY1R
SCHEMBL7058205 0.89 NPY1R (0.57) F7F2F10PRSS1TMPRSS6
SCHEMBL7798487 0.89 NPY1R (0.57) F7F2F10PRSS1TMPRSS6
SCHEMBL8112148 0.85 F2 (0.52) F7F2F10PRSS1TMPRSS6
SCHEMBL8121755 0.82 CTSB (0.46) KLKB1ANPEPCTSL
SCHEMBL8121714 0.81 NPY1R (0.59) NPFFR1NPFFR2NPY1RNPY5RCTSL
SCHEMBL8526149 0.80 F2 (0.54) F7F2F10PRSS1TMPRSS6
SCHEMBL7802954 0.78 NPY1R (0.61) F7F2TMPRSS6NPFFR1NPFFR2
SCHEMBL7802851 0.78 F2 (0.54) F7F2F10PRSS1TMPRSS6
SCHEMBL8121971 0.77 NPY1R (0.58) NPFFR1NPFFR2NPY1RNPY5RCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 EP claimed
EP-1093803-B1 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI AVENTIS (FR) 2008-09-17 EP disclosed
WO-2007077333-A2 USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS L'OREAL (FR) 2007-07-12 WO disclosed
EP-0838217-B1 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI SYNTHELABO (FR) 2003-01-15 EP disclosed
EP-1132463-A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI-SYNTHELABO (FR) 2001-09-12 EP disclosed
EP-1093803-A2 Cosmetic composition comprising antagonist of the neuropeptide Y receptor SANOFI-SYNTHELABO (FR) 2001-04-25 EP disclosed
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 EP disclosed
EP-0838217-A2 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI (FR) 1998-04-29 EP disclosed